Literature DB >> 26215627

Stroke: Poststroke cognitive impairment—what are we measuring?

Adrian Wong1, Vincent Mok1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26215627     DOI： 10.1038/nrneurol.2015.130

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Intraindividual cognitive decline using a brief computerized cognitive screening test.

Authors:  David G Darby; Robert H Pietrzak; Julia Fredrickson; Michael Woodward; Lynette Moore; Amy Fredrickson; Jack Sach; Paul Maruff
Journal:  Alzheimers Dement       Date:  2012       Impact factor: 21.566

Review 2.  Meeting of minds: the medial frontal cortex and social cognition.

Authors:  David M Amodio; Chris D Frith
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

3.  Post-stroke cognitive impairment is common even after successful clinical recovery.

Authors:  H Jokinen; S Melkas; R Ylikoski; T Pohjasvaara; M Kaste; T Erkinjuntti; M Hietanen
Journal:  Eur J Neurol       Date:  2015-06-04       Impact factor: 6.089

4.  Validation of an integrated method for determining cognitive ability: Implications for routine assessments and clinical trials.

Authors:  Olivier Godefroy; Laura Gibbons; Momar Diouf; David Nyenhuis; Martine Roussel; Sandra Black; Jean Marc Bugnicourt
Journal:  Cortex       Date:  2014-02-07       Impact factor: 4.027

5.  Risk factors for incident dementia after stroke and transient ischemic attack.

Authors:  Jie Yang; Adrian Wong; Zhaolu Wang; Wenyan Liu; Lisa Au; Yunyun Xiong; Winnie W C Chu; Eric Y L Leung; Sirong Chen; Christine Lau; Anne Y Y Chan; Alexander Y L Lau; Florence Fan; Vincent Ip; Yannie Soo; Thomas Leung; Chi L Ho; Lawrence K S Wong; Vincent C T Mok
Journal:  Alzheimers Dement       Date:  2014-03-03       Impact factor: 21.566

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials.

Authors:  Jesse M Cedarbaum; Mark Jaros; Chito Hernandez; Nicola Coley; Sandrine Andrieu; Michael Grundman; Bruno Vellas
Journal:  Alzheimers Dement       Date:  2012-06-01       Impact factor: 21.566

8.  The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests.

Authors:  Sarah Tomaszewski Farias; Ernest Harrell; Craig Neumann; Andrew Houtz
Journal:  Arch Clin Neuropsychol       Date:  2003-08       Impact factor: 2.813

Review 9.  Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria.

Authors:  Reisa Sperling; Keith Johnson
Journal:  Continuum (Minneap Minn)       Date:  2013-04

10.  National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.

Authors:  Vladimir Hachinski; Costantino Iadecola; Ron C Petersen; Monique M Breteler; David L Nyenhuis; Sandra E Black; William J Powers; Charles DeCarli; Jose G Merino; Raj N Kalaria; Harry V Vinters; David M Holtzman; Gary A Rosenberg; Anders Wallin; Martin Dichgans; John R Marler; Gabrielle G Leblanc
Journal:  Stroke       Date:  2006-08-17       Impact factor: 7.914
  10 in total
  1 in total

Review 1.  Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study.

Authors:  Natalia S Rost; James F Meschia; Rebecca Gottesman; Lisa Wruck; Karl Helmer; Steven M Greenberg
Journal:  Stroke       Date:  2021-05-27       Impact factor: 10.170
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.